Addition of the CD28 signaling domain to chimeric T-cell receptors enhances chimeric T-cell resistance to T regulatory cells (original) (raw)
Rossig C, Brenner MK . Genetic modification of T lymphocytes for adoptive immunotherapy. Mol Ther 2004; 10: 5–18. ArticleCAS Google Scholar
Mekala DJ, Alli RS, Geiger TL . IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes. Proc Nat Acad Sci 2005; 102: 11817–11822. ArticleCAS Google Scholar
Pule M, Finney H, Lawson A . Artificial T-cell receptors. Cytotherapy 2003; 5: 211–226. ArticleCAS Google Scholar
O'Garra A, Vieira P . Regulatory T cells and mechanisms of immune system control. Nat Med 2004; 10: 801–805. ArticleCAS Google Scholar
D'Orazio TJ, Niederkorn JY . A novel role for TGF-β and IL-10 in the induction of immune privilege. J Immunol 1998; 160: 2089–2098. CASPubMed Google Scholar
Beacher-Allan C, Viglietta V, Hafler D . Human CD4+CD25+ regulatory T-cells. Sem Immunol 2004; 16: 89–97. Article Google Scholar
Coffer PJ, Burgering BMT . Forkhead-box transcription factors and their role in the immune system. Nat Rev Immunol 2004; 4: 889–899. ArticleCAS Google Scholar
Fehérvari Z, Sakaguchi S . CD4+ Tregs and immune control. J Clin Invest 2004; 114: 1209–1217. Article Google Scholar
Biagi E, Rousseau R, Yvon E, Schwartz M, Dotti G, Foster A et al. Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia. Clin Cancer Res 2005; 11: 6916–6923. ArticleCAS Google Scholar
Wierda WG, Cantwell MJ, Woods SJ, Rassenti LZ, Prussak CE, Kipps TJ . CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia. Blood 2000; 96: 2917–2924. CAS Google Scholar
Cooper LJ, Al-Kadhimi Z, DiGiusto D, Kalos M, Colcher D, Raubitschek A et al. Development and application of CD19-specific T cells for adoptive immunotherapy of B cell malignancies. Blood Cells Mol Dis 2004; 33: 83–89. ArticleCAS Google Scholar
Cooper LJN, Topp MS, Serrano LM, Gonzalez S, Chang WC, Naranjo A et al. T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect. Blood 2003; 101: 1637–1644. ArticleCAS Google Scholar
Beyer M, Kochanek M, Darabi K, Popov A, Jensen M, Endl E et al. Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine. Blood 2005; 106: 2018–2025. ArticleCAS Google Scholar
Fu S, Zhang N, Yopp AC, Chen D, Mao M, Chen D et al. TGF-b induces Foxp3+ T-regulatory cells from CD4+CD25- precursors. Am J Transplant 2004; 4: 1614–1627. ArticleCAS Google Scholar
Nicholson IC, Lenton KA, Little DJ, Decorso T, Lee FT, Scott AM et al. Construction and characterization of a functional CD19 specific single chain Fv fragment for immunotherapy of B lineage leukaemia and lymphoma. Mol Immunol 1997; 34: 1157–1165. ArticleCAS Google Scholar
Eshhar Z, Waks T, Gross G, Schindler DG . Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. Pro Natl Acad Sci USA 1993; 90: 720–724. ArticleCAS Google Scholar
Weissman AM, Hou D, Orloff DG, Modi WS, Seuanex H, O'Brien SJ et al. Molecular cloning and chromosomal localization of the human T-cell receptor zeta chain: distinction from the molecular CD3 complex. Proc Natl Acad Sci USA 1988; 85: 9709–9713. ArticleCAS Google Scholar
Riviere I, Brose K, Mulligan RC . Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci USA 1995; 92: 6733–6737. ArticleCAS Google Scholar
Cosset F-L, Takeuchi Y, Battini J-L, Weiss RA, Collins MKL . High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 1995; 69: 7430–7436. CASPubMedPubMed Central Google Scholar
Kane LP, Lin J, Weiss A . It's all Rel-ative: NF_κ_B and CD28 costimulation of T-cell activation. Trends Immunol 2002; 23: 413–420. ArticleCAS Google Scholar
Chambers CA . The expanding world of co-stimulation: the two-signal model revisited. Trends Immunol 2001; 22: 217–223. ArticleCAS Google Scholar
Parry RV, Whittaker GC, Sims M, Edmead CE, Welham MJ, Ward SG . Ligation of CD28 stimulates the formation of a multimeric signaling complex involving Grb-2-associated binder 2 (Gab2), src homology phosphatase-2, and phosphatidylinositol 3-kinase: evidence that negative regulation of CD28 signaling requires the Gab2 pleckstrin homology domain. J Immunol 2006; 176: 594–602. ArticleCAS Google Scholar
Appleman LJ, Tzachanis D, Grader-Beck T, van Puijenbroek AA, Boussiotis VA . Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics. J Mol Med 2001; 78: 673–683. ArticleCAS Google Scholar
Mesa C, Fernandez LE . Challenges facing adjuvants for cancer immunotherapy. Immunol Cell Biol 2004; 82: 644–650. ArticleCAS Google Scholar
Thomas RM, Gao L, Wells AD . Signals from CD28 induce stable epigenetic modification of the IL-2 promoter. J Immunol 2005; 174: 4639–4646. ArticleCAS Google Scholar
Slavik JM, Hutchcroft JE, Bierer BE . CD28/CTLA-4 and CD80/CD86 families: signaling and function. Immunol Res 1999; 19: 1–24. ArticleCAS Google Scholar
Maher J, Brentjens RJ, Gunset G, Riviere I, Sadelain M . Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta/CD28 receptor. Nat Biotechnol 2002; 20: 70–75. ArticleCAS Google Scholar
Haynes NM, Trapani JA, Teng MWL, Jackson JT, Cerruti L, Jane SM et al. Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulation. J Immunol 2002; 169: 5780–5786. ArticleCAS Google Scholar
Teng MWL, Kershaw MH, Moeller M, Smyth MJ, Darcy PK . Immunotherapy of cancer using systemically delivered gene-modified human T-lymphocytes. Human Gene Ther 2004; 15: 699–708. ArticleCAS Google Scholar
Friedmann-Morvinski D, Bendavid A, Waks T, Schindler D, Eshhar Z . Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation. Blood 2005; 105: 3087–3093. ArticleCAS Google Scholar
Fehervari Z, Sakaguchi S . CD4+ Tregs and immune control. J Clin Invest 2004; 114: 1209–1217. ArticleCAS Google Scholar
Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB . Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004; 22: 929–979. ArticleCAS Google Scholar
Letterio JJ . TGF-beta signaling in T cells: roles in lymphoid and epithelial neoplasia. Oncogene 2005; 24: 5701–5712. ArticleCAS Google Scholar